These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6477585)

  • 41. Down-regulation by 17 beta-estradiol of D2 dopamine receptors in the MtTF4 pituitary tumor.
    Albaladejo V; Collu R; Andre J
    Endocrinology; 1984 Jun; 114(6):2344-8. PubMed ID: 6233133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms involved in the prolactin-releasing effect of benserazide.
    Parati EA; Penalva A; Bondiolotti GP; Parenti M; Locatelli V; Picotti GB; Cocchi D; Müller EE
    Eur J Pharmacol; 1984 Jun; 101(3-4):215-21. PubMed ID: 6468496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Demonstration of specific dopamine receptors on human pituitary adenomas.
    Koga M; Nakao H; Arao M; Sato B; Noma K; Morimoto Y; Kishimoto S; Mori S; Uozumi T
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):595-602. PubMed ID: 3577589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies of two thyrotrophin-secreting pituitary adenomas: evidence for dopamine receptor deficiency.
    Bevan JS; Burke CW; Esiri MM; Adams CB; Ballabio M; Nissim M; Faglia G
    Clin Endocrinol (Oxf); 1989 Jul; 31(1):59-70. PubMed ID: 2598481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding.
    Foord SM; Peters JR; Dieguez C; Jasani B; Hall R; Scanlon MF
    Endocrinology; 1984 Jul; 115(1):407-15. PubMed ID: 6428863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance to bromocriptine in prolactinomas.
    Pellegrini I; Rasolonjanahary R; Gunz G; Bertrand P; Delivet S; Jedynak CP; Kordon C; Peillon F; Jaquet P; Enjalbert A
    J Clin Endocrinol Metab; 1989 Sep; 69(3):500-9. PubMed ID: 2760167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistence of a defective tuberoinfundibular dopaminergic function in rats after long-term removal of oestrogen treatment. An in vivo study.
    Cocchi D; Peñalva A; Torpia R; Rossi GL; Müller EE
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):309-14. PubMed ID: 4024849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced dopamine synthesis and release in vitro in the median eminence of rat hypothalamus are associated with involution of estradiol-induced pituitary tumors.
    Arita J; Kojima Y; Kimura F
    Endocrinology; 1989 Apr; 124(4):1998-2004. PubMed ID: 2924731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of dopamine receptors in the MtT/W15 transplantable pituitary tumor by estrogen.
    Lloyd RV; Fields KL
    Mol Cell Endocrinol; 1986 Feb; 44(2):133-9. PubMed ID: 3949067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for alteration in the processing of dopamine in the anterior pituitary gland of aged rats: receptors and intracellular compartmentalization of dopamine.
    Arita J; Reymond MJ; Porter JC
    Endocrinology; 1984 Mar; 114(3):974-9. PubMed ID: 6697971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary.
    Serri O; Renier G; Somma M
    Horm Res; 1985; 21(2):95-101. PubMed ID: 3979949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of pimozide and bromocriptine on anterior pituitary cell proliferation.
    Stepień H; Wolaniuk A; Pawlikowski M
    J Neural Transm; 1978; 42(3):239-44. PubMed ID: 690630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spontaneous sparsely-granulated prolactin-producing pituitary adenomas in aging rats. A prospective study of the effect of bromocriptine.
    McComb DJ; Hellmann P; Kovacs K; Scott D; Evans WS; Burdman JA; Thorner MO
    Neuroendocrinology; 1985 Sep; 41(3):201-11. PubMed ID: 4047338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form.
    George SR; Watanabe M; Di Paolo T; Falardeau P; Labrie F; Seeman P
    Endocrinology; 1985 Aug; 117(2):690-7. PubMed ID: 4017954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological manipulation of anterior pituitary dopamine content in the male rat: relationship to serum prolactin concentration and lysosomal enzyme activity.
    Demarest KT; Riegle GD; Moore KE
    Endocrinology; 1984 Aug; 115(2):493-500. PubMed ID: 6745164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo supersensitivity of the anterior pituitary of old female rats to dopaminergic inhibition of prolactin secretion.
    Cocchi D; Novelli A; Ganzetti I; Müller EE
    Gerontology; 1984; 30(6):345-9. PubMed ID: 6519436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. One minute of bromocriptine irreversibly inhibits prolactin release for hours.
    Cronin MJ; Evans WS; Thorner MO
    Eur J Pharmacol; 1984 Mar; 99(1):85-90. PubMed ID: 6723793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic lead exposure alters dopaminergic mechanisms in rat pituitary.
    Lucchi L; Govoni S; Memo M; Missale C; Spano PF; Trabucchi M
    Toxicol Lett; 1986 Sep; 32(3):255-60. PubMed ID: 3022429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Met-enkephalin-like immunoreactivity in neurointermediate pituitary is decreased by DA receptor stimulation.
    George SR; Kertesz M
    Peptides; 1986; 7(2):277-81. PubMed ID: 3737447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
    Pisarek H; Stepien H; Pawlikowski M
    Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.